Medibank Lifts Revenue but Profit and Asset Backing Ease in First Half

The latest announcement is out from Medibank Private ( (AU:MPL) ).

Medibank Private has reported its financial results for the half year ended 31 December 2025, showing a 5.5% increase in revenue from ordinary activities to $4.50 billion, driven by 4.4% growth in health insurance revenue and a 32.3% rise in other operating revenue. Despite the top-line growth, profit after tax attributable to equity holders declined 11% to $302.9 million and net tangible assets per share fell to 54.7 cents from 65.3 cents, though the board maintained shareholder returns by declaring a fully franked interim dividend of 8.30 cents per share, payable in March 2026.

The company also noted that a fully franked final dividend of 10.20 cents per share had been paid in October 2025 for the prior half year, underscoring its ongoing capital return policy. The combination of higher revenues but lower profit and reduced net tangible assets per share suggests margin or cost pressures within the business, even as Medibank continues to leverage its health insurance portfolio and related services to support shareholder distributions and maintain its position in the Australian private health insurance market.

The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.10 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.

More about Medibank Private

Medibank Private Limited is an Australian private health insurer that provides health insurance products and related services to individuals and families across the country. The company derives the bulk of its revenue from health insurance premiums and also generates additional operating revenue from other health-related services and activities.

Average Trading Volume: 6,241,065

Technical Sentiment Signal: Buy

Current Market Cap: A$12.45B

For an in-depth examination of MPL stock, go to TipRanks’ Overview page.